Health Care Costs Are Rising At Epidemic Proportions - Here's What You Can Do About It!

Written by Blaine G. Dares


Health care costs are now approaching 15% of our national economy andrepparttar economic repercussions have been felt by most American families as employers are unwilling to absorbrepparttar 143088 bulk ofrepparttar 143089 health care cost burden.

In 2004, employer health insurance premiums increased by 11.2% - nearly four timesrepparttar 143090 rate of inflation. The annual premium for an employer health plan covering a family of four averaged nearly $10,000. The annual premium for single coverage averaged $3,695. Health insurance premiums will rise to an average of more than $14,500 for family coverage in 2006.

In 2004, health care spending inrepparttar 143091 United States reached $1.7 trillion, and is projected to reach $1.9 trillion in 2005. Health care spending is 4.3 timesrepparttar 143092 amount spent on national defense.

Overall national health care costs will increase further withrepparttar 143093 implementation of Medicare prescription drug coverage. Too many Americans are uninsured while even a greater percentage have no insurance at all. Uninsured individuals also present a problem for hospitals and other providers who must provide treatment in catastrophic situations without compensation.

Many employees receive restricted coverage and insurance plans that are negotiated between employers and insurance providers limit coverage to a single insurance carrier or an HMO. Prescription drugs arerepparttar 143094 fastest-growing part ofrepparttar 143095 nation's health care expense. Pharmacy bills have become a significant item inrepparttar 143096 budget of most families.

For 37% of Americans without prescription coverage,repparttar 143097 problem is critical. Especially for seniors who constitute 12% ofrepparttar 143098 population but use 37% of prescription drugs. The rest especially those without health insurance, is significantly affected by high drug prices.

IS THE HOPE OF SAVING TYSABRI A REALISTIC ONE?

Written by Newsinferno.com Staff Writers


The FDA has been informed by Biogen Idec Inc. that a fifth person has developed a rare brain disease known as progressive multifocal leukoencephalopathy (PML) after being treated with its multiple sclerosis drug Tysabri. Biogen and its development partner, Elan Corp. PLC of Ireland, had hoped to returnrepparttar drug torepparttar 143087 market despite three previously confirmed cases of PML (with two deaths) as well as a fourth unconfirmed case. Sales ofrepparttar 143088 drug were suspended on February 28 of this year.

Only last week, Biogen was hinting at a strategy for bringingrepparttar 143089 drug back torepparttar 143090 market that included testing all patients forrepparttar 143091 virus that causes PML and stop treatment with Tysabi in time to allowrepparttar 143092 patients to recover. Experts, however, are not sure at what point additional cases of PML may prove to be an insurmountable obstacle to that plan. Each time one of these cases is announced Elan’s stock tumbles in value.

Cont'd on page 2 ==>
 
ImproveHomeLife.com © 2005
Terms of Use